Eli Lilly's Medicare Drug Plan Update on Weight-Loss Medications
Eli Lilly has revealed that some basic Medicare drug plans may not adopt the $50 monthly cap on out-of-pocket expenses for its weight-loss medications. This announcement comes after negotiations between the Medicare agency, Eli Lilly, and Novo Nordisk concluded, addressing a novel coverage strategy for weight-loss drugs.